Uhlelo lokugomela i-Covid 19 lusenendlela ende okufanele luhambe. Uma sikhuluma ngeNdiya, sekuvele kunengxenye yabantu abasagonyiwe. Uma nawe unesisindo phakathi kwezinketho ezimbili lapha sizokhuluma ngeCovaxin vs Covishield.
Uma unqikaza ukuthi ukhethe yiphi noma weqe ekugomeni kwakho noma kwabaseduze kwakho noma obathandayo sikhona ukuze sikusize. Lesi sihloko sizoxoxa, izinga lokusebenza kwe-Covaxin vs Covishield, izwe elikhiqizayo, nokuningi.
Ngakho-ke ngemva kokufunda lesi sihloko esiphelele uzokwazi ukunquma phakathi kwalezi zinketho ezimbili bese ukhetha eyodwa ozoyiphatha esikhungweni esiseduze nawe.
Okuqukethwe
I-Covaxin vs Covishield
Imithi yokugoma emibili evela emithonjeni nemvelaphi ehlukene inamazinga ahlukene okusebenza, nemiphumela engemihle ehambisana nokuphuma ngakunye kwehlukile.
Njengoba lokhu kulawulwa ensimini, idatha emayelana nayo ngayinye iyashintshashintsha ngaso sonke isikhathi. Noma kunjalo, ngolwazi lwakamuva, unganquma phakathi kwalezi zinketho ezimbili ngokwaneliseka.
Uma sizonqoba lesi sibhicongo salolu bhubhane, kubalulekile ukuba sonke sigonywe futhi sivimbele ukubhebhetheka kwalesi sifo. Lokhu kungenziwa kuphela uma sesigonywe ngokugcwele kanjalo nabaseduze nabathandekayo abasizungezile.
Ukugoma okufanele kanye nokulandela izinyathelo zokuphepha ukuphela kwendlela okufanele sinqobe ngayo lesi sifo. Ngakho ukukhetha umthamo olungile kanye nohlobo kuyinketho yokuqala kuwe kanye nesinyathelo esihle endleleni efanele.
Yini iCovaxin
I-Covaxin umuthi wokugoma owakhiwa futhi wakhiwe yi-Bharat Biotech, e-India. Iyelapheka ngokuthatha indlela yendabuko, ngokungafani neModerna nePfizer-BioNTech esekelwe ku-mRNA.
Ngenkathi eyokuqala yenziwa kusetshenziswa i-ejenti ebanga izifo ezikhubazekile, kulokhu, igciwane le-Covid-19 ukuvuselela amasosha omzimba. Lokhu kudinga amashothi amabili anikezwe umuntu omdala ophile kahle onomehluko wezinsuku ezingama-28.
Yini i-Covishield
Ukuyichaza ngendlela efanele esitshela nohlobo lomuthi wokugomela i-Covishield, ihamba kanje, “I-Covishield iyi-recombinant, i-replication-denovirus vector ye-chimpanzee adenovirus efaka ikhodi ye-SARS-CoV-2 Spike (S) glycoprotein. Ngemuva kokuphatha, kuvezwa izakhi zofuzo zengxenye ye-coronavirus ezikhuthaza ukusabela komzimba kumamukeli. ”
Uma ubuza i-Covishield eyenziwe yiliphi izwe. Impendulo elula iNdiya. Umuthi wokugoma i-Oxford-AstraZeneca owenziwe eNdiya yiSerum Institute of India (SII) ubizwa ngokuthi i-Covishield. Njengalokhu okungenhla, inenguqulo engenabungozi yegciwane elibizwa ngokuthi i-adenovirus elivame ukutholakala kuma-Chimpanzi.
Le adenovirus iqukethe izakhi zofuzo ezivela ku-coronavirus yengezwe. Uma lokhu kungena emzimbeni womuntu amangqamuzana atholayo enza amaprotheni e-spike afana nalawo akhiqizwa uma kungena owangempela. Lokhu kutshela amasosha omzimba ukuthi awabone asabela egciwaneni uma evezwa.
I-Covaxin vs Isilinganiso Sokusebenza Se-Covishield
Ithebula elilandelayo lisitshela izinga lokusebenza kwayo yomibili imigomo ngemva kokuqhathanisa ungazinqumela ukuthi yimuphi umuthi wokugomela i-Covid ongcono nokuthi yimuphi ongewona. Kodwa-ke, singancoma ukuthi uphinde uqhathanise nemiphumela emibi.
| Izinga Lokusebenza Kwe-Covaxin | I-Covishield Efficacy Rate |
| Uma isetshenziswa esivivinyweni sesigaba sesi-3, izoba nomthelela wama-78% - 100% | Umphumela wayo usukela ku-70% -kuya ku-90% |
| Ingasetshenziselwa abantu abangaphezu kweminyaka engu-18 ubudala | Kugunyazwe abantu abangaphezu kweminyaka engu-12 ubudala |
| Igebe lokuphatha phakathi kwemithamo lingamaviki ama-4 kuye kwayisi-6 | Isikhathi sokuphatha saso singamaviki ama-4 kuye kwayi-8 |
I-Covaxin vs Covishield Side Effects
Nali ithebula lokuqhathanisa lemiphumela emibi yazo zombili izinhlobo zemithi yokugoma.
| I-Covaxin Side Effects | Covishield Side Effects |
| Imiphumela emibi eyinhloko ingumkhuhlane, ubuhlungu bekhanda, ukucasuka. Ubuhlungu nokuvuvukala noma kokubili endaweni yomjovo. | Imiphumela eyinhloko ukuzwela noma ubuhlungu endaweni yomjovo, ukukhathala, ikhanda elibuhlungu, imisipha noma amalunga, ukugodola, imfiva, nesicanucanu. |
| Nakuba ngokokuhlolwa komtholampilo eminye imiphumela ihlanganisa ubuhlungu bomzimba, isicanucanu, ukukhathala, ukuhlanza, kanye namakhaza. | Eminye imiphumela ihlanganisa izimpawu ezifana ne-Viral influenza, ubuhlungu ezingalweni nasemilenzeni, ukuphelelwa ukudla, njll. |
| Uma kwenzeka kuba nokungezwani komzimba okulandelayo imiphumela emibi ye-Covaxin: ukuphefumula kanzima, ukushaya kwenhliziyo okusheshayo, isiyezi, ubuthakathaka, ukuvuvukala kobuso nomphimbo, nokuqubuka emzimbeni wonke. | Nakuba abanye babika ukozela, isiyezi, umuzwa obuthakathaka, ukujuluka ngokweqile, nokuqubuka noma ukuba bomvu kwesikhumba. |
Uma unikeze imithamo eyodwa noma yomibili yanoma yimuphi umgomo, uyafaneleka ukuthola isitifiketi, lapha indlela ongathola ngayo eyakho ku-inthanethi.
Isiphetho
Lena yonke imininingwane ebalulekile nedingekayo odinga ukuyazi ngaphambi kokuthi unikeze ukwahlulela kwakho kokuthi Covaxin vs Covishield ukusebenza kahle kanye nokuqhathanisa imiphumela eseceleni. Ngokusekelwe kulolu suku ungazibonela kalula ukuthi yimuphi umuthi wokugomela i-Covid ongcono futhi ongewona.